首页> Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions> Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy

Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy

导出原文传递

翻译打印收藏纠错

第一作者： Tijssen Ruben Y.G.

作者： Tijssen Ruben Y.G. ^[1] ; Schaaf Rene J. ^[2] ; Kraak Robin P. ^[3] ; Vink Maarten A. ^[4] ; Hofma Sjoerd H. ^[5] ; Arkenbout E. Karin ^[6] ; Weevers Auke P.J.D. ^[7] ; Kerkmeijer Laura S.M. ; Onuma Yoshinobu ; Serruys Patrick W. ; Beijk Marcel A.M. ; Koch Karel T. ; Baan Jan ; Vis M. Marije ; Piek Jan J. ; Tijssen Jan G.P. ; Henriques Jose P.S. ; Winter Robbert J. ; Wykrzykowska Joanna J.

作者单位： The Department of CardiologyAlbert Schweitzer HospitalDordrecht,The Netherlands ^[1] NHLIImperial College LondonLondon,United Kingdom ^[2] The Department of CardiologyMedical Center LeeuwardenLeeuwarden,The Netherlands ^[3] The Department of CardiologyTergooi HospitalBlaricum,The Netherlands ^[4] Thoraxcenter, Erasmus MCRotterdam,The Netherlands ^[5] Amsterdam UMC, University of AmsterdamHeart Center, Academic Medical CenterAmsterdam,The Netherlands ^[6] The Department of CardiologyOnze Lieve Vrouwe GasthuisAmsterdam,The Netherlands ^[7]

关键词 ACS/NSTEMI bioabsorbable devices/polymers stent thrombosis stent drug eluting

发布时间 2020-06-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交